{"id":101527,"date":"2026-06-08T13:14:34","date_gmt":"2026-06-08T07:44:34","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=101527"},"modified":"2026-06-08T13:14:35","modified_gmt":"2026-06-08T07:44:35","slug":"alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/","title":{"rendered":"Alkem Laboratories Q4 FY26 Results: Revenue, PAT, Net Profit and Key Highlights"},"content":{"rendered":"<div class=\"meta-block\">\u00a0<\/div>\n<p><strong><a href=\"https:\/\/univest.in\/user\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\">Alkem Laboratories<\/a> Q4 FY26 results<\/strong> were declared on May 28, 2026. The company reported net profit of Rs 236 crore for the quarter ended March 31, 2026, +18.1% YoY. Revenue from operations was Rs 3,600 crore, +16.1% YoY. Results are on a consolidated basis. Alkem Laboratories is a Pharmaceuticals (Domestic Formulations and API) company listed on Indian stock exchanges.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\">Click Here &#8211; Get Free Investment Predictions<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Alkem_Laboratories_Q4_FY26_Financial_Highlights\" title=\"Alkem Laboratories Q4 FY26 Financial Highlights\">Alkem Laboratories Q4 FY26 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Alkem_Laboratories_Q4_FY26_Performance_Analysis\" title=\"Alkem Laboratories Q4 FY26 Performance Analysis\">Alkem Laboratories Q4 FY26 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Key_Business_Factors_in_Q4_FY26\" title=\"Key Business Factors in Q4 FY26\">Key Business Factors in Q4 FY26<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Revenue_and_Volume_Performance\" title=\"Revenue and Volume Performance\">Revenue and Volume Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Profitability_and_Margin_Trajectory\" title=\"Profitability and Margin Trajectory\">Profitability and Margin Trajectory<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Sector_and_Macro_Backdrop\" title=\"Sector and Macro Backdrop\">Sector and Macro Backdrop<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#FY27_Outlook\" title=\"FY27 Outlook\">FY27 Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Alkem_Laboratories_Stock_Performance\" title=\"Alkem Laboratories Stock Performance\">Alkem Laboratories Stock Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Key_Risks\" title=\"Key Risks\">Key Risks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Revenue_and_Demand_Risk\" title=\"Revenue and Demand Risk\">Revenue and Demand Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Margin_and_Cost_Volatility\" title=\"Margin and Cost Volatility\">Margin and Cost Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Regulatory_and_Competitive_Risk\" title=\"Regulatory and Competitive Risk\">Regulatory and Competitive Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Frequently_Asked_Questions_on_Alkem_Laboratories_Q4_FY26_Results\" title=\"Frequently Asked Questions on Alkem Laboratories Q4 FY26 Results\">Frequently Asked Questions on Alkem Laboratories Q4 FY26 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#What_is_Alkem_Laboratories_Q4_FY26_net_profit\" title=\"What is Alkem Laboratories Q4 FY26 net profit?\">What is Alkem Laboratories Q4 FY26 net profit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#What_is_Alkem_Laboratories_Q4_FY26_revenue\" title=\"What is Alkem Laboratories Q4 FY26 revenue?\">What is Alkem Laboratories Q4 FY26 revenue?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#When_were_Alkem_Laboratories_Q4_FY26_results_declared\" title=\"When were Alkem Laboratories Q4 FY26 results declared?\">When were Alkem Laboratories Q4 FY26 results declared?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#What_dividend_did_Alkem_Laboratories_declare_for_FY26\" title=\"What dividend did Alkem Laboratories declare for FY26?\">What dividend did Alkem Laboratories declare for FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#What_is_the_FY27_outlook_for_Alkem_Laboratories\" title=\"What is the FY27 outlook for Alkem Laboratories?\">What is the FY27 outlook for Alkem Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#Is_Alkem_Laboratories_a_good_buy_after_Q4_FY26_results\" title=\"Is Alkem Laboratories a good buy after Q4 FY26 results?\">Is Alkem Laboratories a good buy after Q4 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/alkem-laboratories-q4-fy26-net-profit-rs-236-cr-results\/#What_sector_does_Alkem_Laboratories_operate_in\" title=\"What sector does Alkem Laboratories operate in?\">What sector does Alkem Laboratories operate in?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Q4_FY26_Financial_Highlights\"><\/span><strong>Alkem Laboratories Q4 FY26 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26<\/th>\n<th>Q4 FY25<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue from Operations (Rs Cr)<\/strong><\/td>\n<td>3,600<\/td>\n<td>3,100<\/td>\n<td>+16.1%<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT) (Rs Cr)<\/strong><\/td>\n<td>236<\/td>\n<td>199.8<\/td>\n<td>+18.1%<\/td>\n<\/tr>\n<tr>\n<td><strong>Reporting Basis<\/strong><\/td>\n<td colspan=\"3\">Consolidated<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Note: Q4 FY26 PAT Rs 236 Cr (+18.1% YoY). Revenue Rs 3,600 Cr (+16.1% YoY). Strong domestic prescription growth. FY27 guidance: double-digit domestic growth. Always verify from BSE\/NSE audited filings before investment decisions.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Q4_FY26_Performance_Analysis\"><\/span><strong>Alkem Laboratories Q4 FY26 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Alkem Laboratories Q4 FY26 results<\/strong> reflect performance in the January to March 2026 quarter. Revenue grew to Rs 3,600 crore, +16.1% YoY. Net profit of Rs 236 crore reflects the company&#8217;s operational efficiency. Alkem Laboratories operates in the Pharmaceuticals (Domestic Formulations and API) sector.<\/p>\n<p>India&#8217;s macroeconomic backdrop in Q4 FY26 was characterised by sustained GDP growth above 6.5%, government capex of Rs 11.21 lakh crore for FY27, and the RBI&#8217;s accommodative policy stance. The Pharmaceuticals (Domestic Formulations and API) sector benefited from these structural tailwinds during the January to March 2026 quarter.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Q4_FY26\"><\/span><strong>Key Business Factors in Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_and_Volume_Performance\"><\/span><strong>Revenue and Volume Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Revenue from operations grew to Rs 3,600 crore, +16.1% YoY in <strong>Alkem Laboratories Q4 FY26<\/strong>. Strong demand drove this performance. The Pharmaceuticals (Domestic Formulations and API) sector benefited from India&#8217;s domestic demand recovery and infrastructure push in FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_and_Margin_Trajectory\"><\/span><strong>Profitability and Margin Trajectory<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Q4 FY26 net profit of Rs 236 crore demonstrates strong profitability.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sector_and_Macro_Backdrop\"><\/span><strong>Sector and Macro Backdrop<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s macro environment in Q4 FY26 was characterised by GDP growth above 6.5%, budgeted central capex of Rs 11.21 lakh crore for FY27, and the RBI&#8217;s accommodative policy stance. These factors supported business investment and consumer spending. The Pharmaceuticals (Domestic Formulations and API) sector benefited from these structural tailwinds during the quarter ended March 31, 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No dividend was declared for Q4 FY26. The company channelled resources towards operational growth in Q4 FY26.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook\"><\/span><strong>FY27 Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Following the <strong>Alkem Laboratories Q4 FY26 results<\/strong>, investors will focus on management guidance for FY27 covering revenue growth, margin improvement, capital allocation, and order book health. Execution against strategic priorities in FY27 will be critical for sustained performance. India&#8217;s GDP growth trajectory, domestic demand, and sector-specific catalysts will be key drivers for Alkem Laboratories in FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Stock_Performance\"><\/span><strong>Alkem Laboratories Stock Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live price and daily stock recommendations.<\/p>\n<p>Shares of Alkem Laboratories are listed on NSE and BSE. Following the Q4 FY26 results on May 28, 2026, investors should monitor post-results price action and management commentary. Always consult a SEBI-registered financial advisor before investment decisions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks\"><\/span><strong>Key Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_and_Demand_Risk\"><\/span><strong>Revenue and Demand Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any deceleration in India&#8217;s GDP growth, reduction in government capex, or weakening of private consumption could impact demand for Alkem Laboratories&#8217;s products and services in the Pharmaceuticals (Domestic Formulations and API) sector in FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Margin_and_Cost_Volatility\"><\/span><strong>Margin and Cost Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Fluctuations in raw material costs, energy prices, and logistics expenses pose margin risks. Any cost escalation without corresponding pricing power could compress profitability from Q4 FY26 levels.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Regulatory_and_Competitive_Risk\"><\/span><strong>Regulatory and Competitive Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Changes in regulatory frameworks, competitive pressure from domestic and global peers, and customer concentration risks are key watchpoints for Alkem Laboratories investors in FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alkem Laboratories Q4 FY26 results declared on May 28, 2026 showed net profit of Rs 236 crore, +18.1% YoY. The results reflect the company&#8217;s execution capability heading into FY27. Investors should monitor management guidance and sector trends before making investment decisions.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Verify all data from BSE\/NSE audited filings.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Alkem_Laboratories_Q4_FY26_Results\"><\/span><strong>Frequently Asked Questions on Alkem Laboratories Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Alkem_Laboratories_Q4_FY26_net_profit\"><\/span><strong>What is Alkem Laboratories Q4 FY26 net profit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories Q4 FY26 net profit was Rs 236 crore, +18.1% YoY. Results declared May 28, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Alkem_Laboratories_Q4_FY26_revenue\"><\/span><strong>What is Alkem Laboratories Q4 FY26 revenue?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories Q4 FY26 revenue was Rs 3,600 crore, +16.1% YoY.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Alkem_Laboratories_Q4_FY26_results_declared\"><\/span><strong>When were Alkem Laboratories Q4 FY26 results declared?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories Q4 FY26 results were declared on May 28, 2026 at the board meeting approving audited financial statements for the quarter and year ended March 31, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_dividend_did_Alkem_Laboratories_declare_for_FY26\"><\/span><strong>What dividend did Alkem Laboratories declare for FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No dividend was declared for Q4 FY26. Verify from BSE\/NSE filings for record date and payout schedule.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_FY27_outlook_for_Alkem_Laboratories\"><\/span><strong>What is the FY27 outlook for Alkem Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Following Alkem Laboratories Q4 FY26 results, management guidance on revenue growth, margin improvement, and capital allocation shapes FY27 expectations. Consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Alkem_Laboratories_a_good_buy_after_Q4_FY26_results\"><\/span><strong>Is Alkem Laboratories a good buy after Q4 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investment decisions in Alkem Laboratories require assessment of fundamentals, valuation, sector outlook, and personal risk tolerance. This article is for educational purposes only. Consult a SEBI-registered financial advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Alkem_Laboratories_operate_in\"><\/span><strong>What sector does Alkem Laboratories operate in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories operates in the Pharmaceuticals (Domestic Formulations and API) sector. The company is listed on Indian stock exchanges and declared Q4 FY26 results on May 28, 2026.<\/p><p><\/p>","protected":false},"excerpt":{"rendered":"<p>Alkem Laboratories Q4 FY26 results: Revenue Rs 3,600 Cr (+16.1% YoY). PAT Rs 236 Cr. Declared May 28, 2026.<\/p>\n","protected":false},"author":35,"featured_media":109693,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-101527","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1780904690:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["Alkem Laboratories Q4 FY26: Revenue Rs 3,600 Cr, Up 16.1%"],"rank_math_description":["Alkem Laboratories Q4 FY26 results: Revenue Rs 3,600 Cr (+16.1% YoY). PAT Rs 236 Cr. Declared May 28, 2026."],"rank_math_focus_keyword":["Alkem Laboratories Q4 FY26"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_wp_old_date":["2026-05-29"],"_thumbnail_id":["109693"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["16124"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/05\/Alkem-Laboratories-Q4-FY26.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/101527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=101527"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/101527\/revisions"}],"predecessor-version":[{"id":109694,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/101527\/revisions\/109694"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/109693"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=101527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=101527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=101527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}